Thomson Medical Group expects loss for H1

This is primarily due to weaker performance in the Malaysia market.

Thomson Medical Group, together with its subsidiaries, has announced an expected after-tax loss for the six months ended 31 December 2024, based on a preliminary review of its unaudited financial results.

The anticipated loss is attributed primarily to weaker performance in the Malaysia market, which was impacted by the termination and discounting of certain insurance contracts. Additionally, higher interest expenses related to the acquisition of Far East Medical Vietnam Limited (FEMVN) and the cessation of certain projects in Singapore have contributed to the Group's financial challenges during the period.

TMG will release its unaudited financial results for the period on or before 14 February 2025.

Shareholders and investors are advised to exercise caution when trading TMG securities and to seek professional advice if needed.

Follow the link for more news on

Thomson Medical

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia